6.72

8.56% 0.53

Pre-market: 7.00 0.28 +4.17%

Lixte Biotechnology Holdings Inc (LIXT)

Overview News Price History Financials Discussions Forecast Stock Split

Lixte Biotechnology Holdings Inc stock is traded at $6.72, with a volume of 345.33K. It is up +8.56% in the last 24 hours and up +30.23% over the past month. Lixte Biotechnology Holdings Inc is a clinical-stage biopharmaceutical and proton cancer therapy company focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies. The company's drug product pipeline is focused on inhibitors of protein phosphatase 2A, which is used to enhance cytotoxic agents, radiation, immune checkpoint blockers and other cancer therapies. Its product is LB-100 for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer. The company operates in a single reportable segment, which consists of the development of cancer treatments.

Previous Close:

$6.19

Open:

$6.3

24h Volume:

345.33K

Relative Volume:

2.96

Market Cap:

$116.84M

Revenue:

Net Income/Loss:

$-7.29M

P/E Ratio:

-5.9824

EPS:

-1.1233

Net Cash Flow:

$-7.00M

1W Performance:

+1.05%

1M Performance:

+30.23%

6M Performance:

+68.42%

1Y Performance:

+489.47%

1-Day Range:

$6.30

$6.80

1-Week Range:

$5.875

$7.51

52-Week Range:

$0.64

$7.51

Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile

Name

Lixte Biotechnology Holdings Inc

Sector

Healthcare (1104)

Industry

Biotechnology (621)

Phone

310 203 2902

Address

433 PLAZA REAL, BOCA RATON

Employee

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

LIXT's Discussions on Twitter

Compare LIXT vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LIXT Lixte Biotechnology Holdings Inc	6.72	116.84M	0	-7.29M	-7.00M	-1.1233
VRTX Vertex Pharmaceuticals Inc	450.46	114.33B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	614.98	64.47B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	884.20	54.99B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	287.80	38.42B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	160.06	34.03B	742.00K	-1.37B	-1.07B	-7.0731

Lixte Biotechnology Holdings Inc Stock (LIXT) Latest News

Jun 15, 2026

From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch - marketscreener.com

Jun 15, 2026

Jun 14, 2026

LIXTE Biotechnology sings deal to acquire 100% of NOMAD to meet grid demand - MSN

Jun 14, 2026

Jun 12, 2026

LIXT Transforms from Biotech to Power Infrastructure Amid AI Dem - GuruFocus

Jun 12, 2026

LIXT Enters Agreement to Acquire Nomad Transportable Power Syste - GuruFocus

Jun 12, 2026

LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, Pivots to Energy Storage - MEXC

Jun 12, 2026

The New Bottleneck Isn’t Computing Power — It’s Just Power - lincolnjournal.com

Jun 12, 2026

Lixte Biotechnology to acquire NOMAD Power Systems - Investing.com

Jun 12, 2026

LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS) - The Manila Times

Jun 12, 2026

LIXTE Biotechnology Holdings, Inc. to Acquire NOMAD Transportable Power Systems, Inc. and Rebrand as NOMAD Power Solutions - Quiver Quantitative

Jun 12, 2026

Mobile grid batteries for AI boom: LIXTE to acquire NOMAD BESS leader - Stock Titan

Jun 12, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Jun 12, 2026

LIXTE to acquire NOMAD Transportable Power Systems for BESS pivot - grafa.com

Jun 12, 2026

Jun 09, 2026

Lixte Biotechnology Holdings (LIXT) Advances 3.3% as Investors Eye Key Resistance at $7.21Low Vol ETF - newsline.com

Jun 09, 2026

Lixte Biotechnology (NASDAQ:LIXT) holders report 5.1% stake in company - Stock Titan

Jun 09, 2026

Jun 05, 2026